2024, Drug Development and Pharma Companies

AI-driven drug company secures $372m Series D funding

Drug Discovery World

JULY 1, 2024

Formation Bio, a tech-driven and AI-native pharma company, has raised $372 million in a Series D financing. “We are thrilled to partner with the Formation Bio team on their journey to build an AI-enabled pharma company,” said Scott Kupor, Managing Partner at a16z.

Pharma Companies

Pharma Companies Licensing Licensing Drugs

Fierce Biotech Week

Fierce BioTech

SEPTEMBER 30, 2024

Fierce Biotech Week Fierce Biotech Week features insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies on emerging trends and market dynamics that will help effectively prioritize R&D spend, optimize drug development and clinical operations, and navigate capital raising and partnering deals.

Pharma Companies

Pharma Companies Drug Development Marketing Drugs

ADCs: the next generation of targeted therapies

Drug Discovery World

SEPTEMBER 25, 2024

Antibody drug conjugates (ADCs) are among the hottest properties in pharma, powerful anticancer drugs that target tumours and deliver a lethal payload that destroys them, while leaving healthy tissues untouched. He adds: “The rise of ADCs as a priority for big pharma companies can be attributed to several factors.

Therapies

Therapies Pharma Companies FDA Approval FDA

Disrupting the CRO Model: Altasciences Participates in Documentary Series for 2024 Global Health Summit

Alta Sciences

APRIL 5, 2024

The mini documentary explores transformation in the slow-to-change drug development industry. Leaders from Altasciences dive into the obstacles and inefficiencies of the traditional outsourcing relationship between CROs and drug sponsors, and how Altasciences has broken from tradition to address these challenges.

Drug Development

Drug Development Pharma Companies Marketing International

SLAS2024 speaker update: How tech is reducing failure rates in clinical trials

Drug Discovery World

JANUARY 26, 2024

Be sure to attend the Ignite Theater at SLAS2024 in Boston on 5 and 6 February 2024. Dr Bentwich will present on ‘ How artificial intelligence and patient-on-a-chip are improving drug development ’ on Tuesday 6 February at 3pm.

Clinical Trials

Clinical Trials Trials Animal Testing Pharma Companies

Europe: Where is the drug discovery innovation?

Drug Discovery World

MAY 6, 2024

Even before this, however, Amsterdam was established as an important centre for drug development. Under the partnership, KWF will provide funding to enable the development of select early phase clinical programmes through Cancer Research UK’s Centre for Drug Development (CDD).

Drugs

Drugs Science Molecular Biology Clinical Trials

Join DDW for the SLAS2024 Ignite Theater ‘Innovation from lab to patient’

Drug Discovery World

JANUARY 21, 2024

Bushell will discuss the history and technological underpinnings of induced proximity, the lessons learned from the PROTAC (proteolysis-targeting chimeric) example, and how technology can create enhancement-targeting chimeric, or ENTAC, drugs and fully realise the potential of targeted protein enhancement. Is pharma’s commercial model dying?

Vaccine

Vaccine Computational Chemistry Animal Testing Engineering

What is the largest CRO in the US?

Vial

MARCH 1, 2024

Leading Global CROs To advance new therapies, pharma, biotech, and medical device sponsors engage CROs to help navigate the complex landscape of drug development and regulatory pathways and to manage clinical trials efficiently, ethically, and in compliance with good clinical practice ( GCP ) standards. of total revenue).

Clinical Trials

Clinical Trials Clinical Research Laboratories Trials

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy

Alta Sciences

MARCH 27, 2024

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy nbartlett Wed, 03/27/2024 - 20:21 Here at Altasciences, Eryn is responsible for guiding regulatory strategies , conducting gap analyses, and leading interactions with regulatory agencies dur ing early drug development.

Drug Development

Drug Development Medical Schools Pharma Companies Drugs

Fibrosis research: Advances and challenges

Drug Discovery World

JANUARY 24, 2024

Fibrocor is on track to complete all IND-enabling work to support IND filing and initiation of clinical trials in 2024. Phase I of the clinical program will dose healthy volunteers with single ascending doses of FIB992 before proceeding to a multiple ascending dose study where the drug is administered for a two-week period.

Small Molecule

Small Molecule Research Pharma Companies Disease

Article FDA Thank You FDA gives companies leeway to go after misinformation, but not free reign

Agency IQ

JULY 12, 2024

While the policy is similar in some respects to one first created by the FDA in 2014, the latest version is considerably more detailed regarding what it will – and won’t – allow companies to do. BY LAURA DIANGELO, MPH | JUL 10, 2024 3:47 PM CDT Regulatory background: The FDA is responsible for overseeing information about regulated products.

FDA

FDA Regulations Production Science

Why more work is needed to fight antimicrobial resistance

Drug Discovery World

MAY 7, 2024

So, a lot of effort on iiCON’s part but what about developments within the wider industry? Last year, there was activity within the AMR space in regard to developers attempting to bring new treatments to market. They’re not being engaged in it.

Vaccine

Vaccine Pharmaceutical Companies Clinical Trials Production

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

APRIL 29, 2024

Joining Isomorphic Labs in October 2024, I’m thrilled to be part of their mission to revolutionize DD through AI/ML. big pharma or startups/spin off? thanks Big pharma experienced is very well respected within biotech or small-startups. Where do you enjoy more to work? What pro/cons?

Bioinformatics

Bioinformatics Molecular Biology Drugs Cell Based Assays

Scaling Phage Therapy

Codon

FEBRUARY 13, 2024

But thankfully there are groups — from charities and start-ups to the non-profit arms of major pharma companies — looking specifically at more public-health-focused approaches to scaling phage therapy for these parts of the world. Asimov Press (2024). Cite this essay: Tom Ireland. Scaling Phage Therapy."

Therapies

Therapies Virus DNA Clinical Trials

Drug Discovery Digest

AI-driven drug company secures $372m Series D funding

Fierce Biotech Week

Trending Sources

ADCs: the next generation of targeted therapies

Disrupting the CRO Model: Altasciences Participates in Documentary Series for 2024 Global Health Summit

SLAS2024 speaker update: How tech is reducing failure rates in clinical trials

Europe: Where is the drug discovery innovation?

Join DDW for the SLAS2024 Ignite Theater ‘Innovation from lab to patient’

What is the largest CRO in the US?

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy

Fibrosis research: Advances and challenges

Article FDA Thank You FDA gives companies leeway to go after misinformation, but not free reign

Why more work is needed to fight antimicrobial resistance

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Scaling Phage Therapy

Stay Connected